These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3887382)

  • 21. Interplay of various factors in glucose-induced hyperkalemia during captopril treatment.
    Radó JP; Gercsák G; Bános C
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):69-76. PubMed ID: 3514489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone and magnesium in essential arterial hypertension.
    Garcia Zozaya JL; Padilla Viloria M; Castro A
    Clin Physiol Biochem; 1988; 6(6):293-300. PubMed ID: 3208481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North].
    Iakovlev VA; Sokol LIu; Karlov VA
    Klin Med (Mosk); 1998; 76(1):35-7. PubMed ID: 9532913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)].
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasma aldosterone during haemodialysis in patients with terminal renal failure].
    Schnurr E; Küppers H; Wiesen K; Grabensee B
    Dtsch Med Wochenschr; 1976 Jul; 101(30):1120, 1125-8. PubMed ID: 1278056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blunted aldosterone responsiveness to angiotensin II in normotensive subjects with familial predisposition to essential hypertension.
    Beretta-Piccoli C; Pusterla C; Städler P; Weidmann P
    J Hypertens; 1988 Jan; 6(1):57-61. PubMed ID: 3351294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
    Davies DL; Beevers DG; Brown JJ; Cumming AM; Fraser R; Lever AF; Mason PA; Morton JJ; Robertson JI; Titterington M; Tree M
    J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346
    [No Abstract]   [Full Text] [Related]  

  • 29. Diltiazem enhances potassium disposal in subjects with end-stage renal disease.
    Solomon R; Dubey A
    Am J Kidney Dis; 1992 May; 19(5):420-6. PubMed ID: 1585928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of aldosterone binding in human plasma.
    Zipser RD; Meidar V; Horton R
    J Clin Endocrinol Metab; 1980 Jan; 50(1):158-62. PubMed ID: 7350179
    [No Abstract]   [Full Text] [Related]  

  • 31. [Behavior of blood sugar in subjects of essential hypertension after insulin and double-insulin loading tests].
    SCHRODER J
    Arztl Forsch; 1956 Dec; 10(12):I/582-5. PubMed ID: 13394435
    [No Abstract]   [Full Text] [Related]  

  • 32. Low potassium levels in the serum in experimental conditions.
    BEKAERT J; DEMEESTER G
    Arch Int Physiol; 1952 Jun; 60(2):211-2. PubMed ID: 12977444
    [No Abstract]   [Full Text] [Related]  

  • 33. Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance.
    Cooke CR; Horvath JS; Moore MA; Bledsoe T; Walker WG
    J Clin Invest; 1973 Dec; 52(12):3028-32. PubMed ID: 4750439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of potassium and ACTH on plasma-aldosterone regulation in anephric patients.
    Olgaard K; Madsen S
    Proc Eur Dial Transplant Assoc; 1976; 12():313-20. PubMed ID: 180522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldosterone response to modulation of potassium in patients on dialysis or with essential hypertension.
    Olgaard K; Langhoff E; Tvedegaard E; Madsen S; Hammer M; Daugaard H; Egfjord M; Ladefoged J
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():815-9. PubMed ID: 3887382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An abnormal response of the adrenal cortex to insulin: glucose in essential hypertension.
    Olgaard K; Tvedegaard E; Langhoff E; Hammer M; Madsen S; Daugaard H; Egfjord M; Ladefoged J
    J Clin Hypertens; 1986 Dec; 2(4):354-9. PubMed ID: 3543229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma aldosterone in anephric and non-nephrectomized dialysis patients in relation to changes in plasma potassium without change in total potassium balance.
    Olgaard K
    Acta Med Scand; 1975 Sep; 198(3):213-8. PubMed ID: 1180127
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.